New York, NY, United States of America

Chia Chi Ho

This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent. Top assignees: Pfizer Corporation, University of California. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chia Chi Ho. Retrieved from https://idiyas.com/inventor/chia-chi-ho-ufi4r0k4

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Chia Chi Ho: Innovator in Immunology

Introduction

Chia Chi Ho is a notable inventor based in New York, NY (US). He has made significant contributions to the field of immunology, particularly through his innovative work on lymphocyte function-associated antigen 3 (LFA3) variant polypeptides.

Latest Patents

Chia Chi Ho holds a patent for "Lymphocyte function-associated antigen 3 (LFA3) variant polypeptides and methods of use thereof to treat CD2-mediated immune diseases, disorders or conditions." This invention provides LFA3 polypeptide molecules, including variant LFA3 fusion polypeptide molecules. The patent encompasses various uses and associated methods for utilizing these LFA3 polypeptide molecules in medical treatments.

Career Highlights

Throughout his career, Chia Chi Ho has worked with prominent organizations such as Pfizer Corporation and the University of California. His experience in these institutions has allowed him to advance his research and contribute to the development of innovative therapeutic solutions.

Collaborations

Chia Chi Ho has collaborated with notable colleagues, including Natasha K. Crellin and Lauren K. Ely. These partnerships have further enriched his research endeavors and expanded the impact of his inventions.

Conclusion

Chia Chi Ho's work in developing LFA3 polypeptide molecules represents a significant advancement in treating immune-related diseases. His contributions to the field of immunology continue to influence research and therapeutic practices.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…